Generics, authorised low‑cost versions and regulatory action are reshaping South Africa’s GLP‑1 weight‑loss drug market as patients seek cheaper, safer access.
Weight-loss injections like Ozempic and Wegovy have been hailed as game changers, promising dramatic results in the battle against obesity and type 2 diabetes. Yet for...